XHKG3689
Market cap77mUSD
Dec 23, Last price
1.80HKD
1D
0.00%
1Q
-25.00%
Jan 2017
-84.07%
IPO
-81.82%
Name
Guangdong Kanghua Healthcare Co Ltd
Chart & Performance
Profile
Guangdong Kanghua Healthcare Co., Ltd., an investment holding company, primarily operates private hospitals in the People's Republic of China. The company operates through Hospital Services, Rehabilitation and Other Healthcare Services, Sale of Pharmaceutical Products, and Elderly Healthcare Services segments. It provides inpatient and outpatient healthcare, and physical examination services. The company also offers VIP inpatient and outpatient services; assisted reproductive services for couples with infertility disorders; surgical and non-surgical cosmetic treatment options; and laser treatment and skin care services, including acne, acne scarring, stretch marks, and pigmentation treatment, as well as laser hair removal services. In addition, it provides rehabilitation services to patients with physical or mental disabilities; and other healthcare-related services, including elderly care and training service for the disabled, as well as sells pharmaceutical products and medical consumables. Further, the company offers elderly healthcare services, including assisted living, adult daycare, long-term care, residential care, and hospice care to the aged patients. It operates Kanghua Hospital, Renkang Hospital, and Kangxin Hospital. The company was formerly known as Dongguan Kanghua Enterprise Co., Ltd. and changed its name to Guangdong Kanghua Healthcare Co., Ltd. in December 2015. The company was incorporated in 2002 and is headquartered in Dongguan, the People's Republic of China. Guangdong Kanghua Healthcare Co., Ltd. is a subsidiary of Dongguan Kanghua Investment Group Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 2,041,858 10.63% | 1,845,633 -5.54% | 1,953,944 11.97% | |||||||
Cost of revenue | 1,920,468 | 1,813,702 | 1,827,254 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 121,390 | 31,931 | 126,690 | |||||||
NOPBT Margin | 5.95% | 1.73% | 6.48% | |||||||
Operating Taxes | 62,406 | 41,573 | 62,284 | |||||||
Tax Rate | 51.41% | 130.20% | 49.16% | |||||||
NOPAT | 58,984 | (9,642) | 64,406 | |||||||
Net income | 121,062 336.48% | 27,736 -58.56% | 66,925 -233.70% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 78,302 | 70,432 | 65,217 | |||||||
Long-term debt | 456,037 | 508,471 | 613,011 | |||||||
Deferred revenue | 252,111 | 282,119 | ||||||||
Other long-term liabilities | (252,111) | (282,119) | ||||||||
Net debt | (217,582) | 232,117 | 367,559 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 204,195 | 221,404 | 333,369 | |||||||
CAPEX | (130,885) | (115,200) | (171,176) | |||||||
Cash from investing activities | (107,724) | (83,159) | (299,332) | |||||||
Cash from financing activities | (55,563) | (110,880) | 23,269 | |||||||
FCF | 206,080 | 80,282 | 13,326 | |||||||
Balance | ||||||||||
Cash | 718,521 | 754,337 | 770,343 | |||||||
Long term investments | 33,400 | (407,551) | (459,674) | |||||||
Excess cash | 649,828 | 254,504 | 212,972 | |||||||
Stockholders' equity | 799,313 | 804,293 | 776,213 | |||||||
Invested Capital | 1,274,281 | 1,654,371 | 1,723,276 | |||||||
ROIC | 4.03% | 3.78% | ||||||||
ROCE | 6.27% | 1.65% | 6.47% | |||||||
EV | ||||||||||
Common stock shares outstanding | 334,394 | 334,394 | 334,394 | |||||||
Price | 1.90 4.97% | 1.81 | ||||||||
Market cap | 635,349 4.97% | 605,253 | ||||||||
EV | 491,109 | 852,008 | ||||||||
EBITDA | 264,469 | 181,372 | 276,133 | |||||||
EV/EBITDA | 1.86 | 4.70 | ||||||||
Interest | 12,055 | 15,043 | 19,812 | |||||||
Interest/NOPBT | 9.93% | 47.11% | 15.64% |